⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 15, 2024Open Access

Supplemental Table 1 from Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II

Glenn J. Hanna Punita Grover Andrew Elliott Julie McGrath Joanne Xiu Ammar Sukari Jennifer M. Johnson Trisha M. Wise‐Draper

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplemental Table 1. Overall survival stratified by MYC and TP63 expression patterns and adenoid cystic carcinoma (ACC)-type I and II phenotyping.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hanna et al. (2024) studied this question.

synapsesocial.com/papers/68e6a14db6db643587624fc5 https://doi.org/10.1158/1078-0432.25826462.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table 1 from Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II2024
2Data from Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II2024
3Prognostic Impact of MYC/TP63 Molecular Subtypes in Adenoid Cystic Carcinoma: A Meta-AnalysisMeta-Analysis · 2026
4Integrated proteogenomic profiling to reveal prognostic subtypes and actionable targets in adenoid cystic carcinoma.Original Research · 2026
5Supplementary Data 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors2024